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Plain English Summary (up to 250 words) 
Little qualitative research has been done to find out what life is like for people living with and beyond cancer 
alongside other long term illnesses (such as heart disease or diabetes). It makes sense to ask people in this 
situation to have a say in issues that affect them. This paper reports on a patient involvement exercise to help 
identify the main things people living with and beyond cancer with other long term illness would like 
researchers to find out more about in order to improve their experiences. People were asked to give their 
views at a workshop and via an online survey. Other researchers interested in this area were also asked for 
their views. Five key priorities were identified: the diagnostic journey, the burden of symptoms, managing 
medications, addressing the needs of informal carers, and service provision. The challenges of this kind of 
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patient involvement exercise are also discussed, focussing on ethical concerns and making discernible changes 
to people’s lives.  
Abstract (up to 350 words) 
Background: People living with and beyond cancer are more likely to have comorbid conditions and poorer 
mental and physical health, but there is a dearth of in-depth research exploring the psychosocial needs of 
people experiencing cancer and comorbid chronic conditions. A patient partnership approach to research 
prioritisation and planning can ensure outcomes meaningful to those affected and can inform policy and 
practice accordingly, but can be challenging.  
Methods: We aimed to inform priorities for qualitative inquiry into the experiences and support needs of 
people living with and beyond cancer with comorbid illness using a partnership approach. A three-step 
process including a patient workshop to develop a consultation document, online consultation with patients, 
and academic expert consultation was carried out. The research prioritisation process was also appraised and 
reflected upon.  
Results: Six people attended the workshop, ten responded online and eight academic experts commented on 
the consultation document. Five key priorities were identified for exploration in subsequent qualitative 
studies, including the diagnostic journey, the burden of symptoms, managing medications, addressing the 
needs of informal carers, and service provision. Limitations of patient involvement and reflections on 
procedural ethics, and the challenge of making measurable differences to patient outcomes are discussed.  
Conclusions: Findings from this research prioritisation exercise will inform planned qualitative work to explore 
patients’ experiences of living with and beyond cancer with comorbid illness. Including patient partners in the 
research prioritisation process adds focus and relevance, and feeds into future work and recommendations to 
improve health and social care for this group of patients. Reflections on the consultation process contribute to 
a broadening of understanding the field of patient involvement.  
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Introduction 
Approximately 363 000 people are diagnosed with a new cancer each year in the UK and the incidence is 
predicted to rise by a further 2% by 2035 (1). Cancer survival has also more than doubled in the last 40 years 
from 24% to 50% of people living disease-free for 10 years or more as early detection and treatment improves 
(1).  Cancer survival is couched in the context of an ageing society, with the number of UK residents over 65 
predicted to rise to 26% of the total population by 2041, compared with 15.8% in 1991. Therefore, more 
people and living with and beyond cancer (2).  A range of health and social care needs of people living with 
and beyond cancer have been described (3, 4).  However, these are often complicated by the presence of 
comorbid conditions. As many as 78% of cancer patients are living with at least one other condition, and the 
number of conditions increases as people get older (5, 6). Cancer patients are more likely to have more 
comorbid conditions and therefore experience poorer physical and mental health than those without cancer 
(7). There is, therefore, a need for a better understanding of the support needs of this patient group, and for 
service developments to better meet these needs (8).  
The research agenda related to living beyond cancer has received increased attention in recent years (9), with 
the development of the National Survivorship Initiative (10) in England and Wales.  Survivorship is also a key 
focus of Scotland’s Better Cancer Care (11). A growing body of research is being developed around 
understanding the psychosocial dimensions of living with and beyond cancer (c.f.(3, 12-15). There have also 
been significant efforts to set priorities for research in this area with the National Cancer Research Institute 
(NCRI) and the James Lind Alliance (www.jameslindalliance.co.uk) recently reporting on the ‘Top 10 research 
priorities for people living with and beyond cancer’ (https://www.ncri.org.uk/lwbc/#lwbc_questions).  Better 
coordination of care for people with complex health needs (to include multiple conditions) was identified as 
priority number three. 
One important dimension of this field of study is the psychosocial experience of living with existing comorbid 
conditions alongside cancer, across the illness trajectory and beyond. At present, little has been published 
focusing on the experience of cancer and comorbid conditions and its implications for coordinated, quality 
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care. A recent systematic review conducted by the authors (following PRISMA guidance) has highlighted the 
gaps in this field of research (16). Themes for further exploration identified in the evidence synthesis included: 
Interaction between cancer and comorbid conditions, symptom experience, illness identities and ageing, self-
management and the role of primary and secondary care. The need for further research to understand 
experiences of people with cancer and other multi-morbidity has also been identified elsewhere in the 
literature c.f. (17-20), and has been highlighted as one of the NCRI Top Ten research priorities (priority three). 
Further in-depth work is needed to explore what cancer means to people in relation to their other health 
conditions, and whether these illnesses are experienced separately or in a more holistic way. This may be less 
obvious to clinicians and those researching illness narratives, where the focus tends to remain on one 
condition. As new models of survivorship care continue to shift and accommodate patients with a complex 
picture of health, there are also implications for the changing roles of primary and secondary care (10, 17, 20, 
21), care quality (22) and self-management (23). 
Background to patient partnership and rationale 
A patient partnership model - defined here as working in collaboration with relevant patient groups as 
partners to develop, inform and be involved in health research, rather than a unidirectional research model 
with patient as participants whom data is collected on (24) -  ensures that objectives and findings of 
subsequent studies are meaningful and responsive to patients’ needs, ultimately translating into relevant 
policy and practice (25). Methods of stakeholder involvement in research prioritisation, including patients, is a 
fast developing field. In addition to more established techniques such as the Delphi method, recently applied 
to health care research (26, 27), a proliferation of approaches are being suggested in the literature to provide 
structure and transparency to the process (28). More structured methods, such as those of the James Lind 
Alliance and used by the Child Health Nutrition and Research Initiative (28, 29), are expected to take 
precedence over the coming years. A  tailored partnership approach that is patient-centred was favoured 
here, adapting aspects of the existing approaches to reflect the small scale of the exercise and the exploratory 
aims of the study (24, 30). The approach drew on tenets of the outlined approaches, particularly the iterative 
workshop and consultation method in the early phase of the Delphi approach (round one)  and subsequent 
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online questionnaires modelling the eDelphi approach (rounds two and three), also resonating with 
crowdsourcing techniques of consulting relevant audiences and using online methods (31) to consult with 
patients, their informal carers and academic experts in the field of cancer survivorship, multi-morbidity and 
follow-up care. A patient partnership approach is not without its challenges, however, and poses questions 
around purpose, effective processes and ethics that need to be addressed (32, 33).  
This paper reports on small-scale research prioritisation work. It involved consulting with patients, informal 
carers and academic experts and combining the findings with our prior systematic review (16), to inform a 
follow on in-depth qualitative study exploring patient and informal carer experiences of living with and 
beyond cancer with comorbid illness, and health care provider experiences of caring for this patient group. 
This paper presents the outcomes of the research prioritisation exercise and reflects on the methodology and 
challenges posed by the process.  
The consultation process asked:  
 What are the key topics and priorities identified by individuals with a diagnosis of cancer and a 
comorbid illness and their informal carers? 
 How can these priorities be further developed and refined with online academic expert input? 
 What are the key methodological challenges posed by this research prioritisation process and what 
are its strengths and shortfalls? 
The paper follows GRIPP2 reporting guidelines (see Additional File 1).  
Research prioritisation exercise approach 
The RPE phase of the wider project involved three components: a patient and public consultation event 
resulting in the development of a consultation document, online social media and email consultation with 
consumers on the document, and finally, consultation with academic experts to refine and finalise the (see 
figure 1). As patient partnership engagement, this work did not require NHS ethical approval but did go 
through institutional ethics to review the ethical integrity of the planned approach.  
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Figure 1: The Research Prioritisation Process 
Patient and carer consultation event 
People with a diagnosis of cancer and one or more comorbid illnesses and their informal carers were invited 
to attend a facilitated discussion workshop to share their views on key topics for research exploring the 
experience of living with and beyond cancer with comorbid illness. The workshop was modelled on the 
consultation approach in the first round of the Delphi process (28), and is a similar approach to that used 
previously (28, 34). Relevant quality markers developed as part of the Delphi and CHNRI methods informed 
the planning and implementation of the workshop, such as adequate planning and preparation, inclusiveness 
of relevant stakeholders and transparency in reporting (29, 35). 
Potential workshop attendees were invited via a poster advertised (either displayed in print or sent 
electronically) on Twitter and through the Edinburgh Cancer Centre, Edinburgh Maggie’s Centre, local GP 
surgeries, and consumer panels of such groups as the South East Scotland Cancer Network (SCAN) Patient 
Involvement Group and local charity support groups. People had the opportunity to register their interest and 
receive an information sheet to aid their decision to attend. Attendees were offered support with travel 
expenses to the central Edinburgh venue.  
The workshop 
As attendees arrived they were offered lunch and there was informal discussion to build rapport among the 
group. The researcher, Debbie Cavers (DC), and consumer member of the research team Elspeth Banks (EB) 
then gave an introduction on the format for the day and some insights into patient and public involvement in 
research. It was planned that the room would then be split into small groups for in-depth discussion of ideas 
for research, with each group facilitated by experienced members of staff working in the field of cancer 
experience, as well as EB, who has considerable experience of consumer involvement and has supported 
similar events in the past. However, due to small numbers of attendees, only one group was formed with the 
facilitators. Attendees were prompted with suggested topics and questions. Post-it notes and marker pens 
were used to annotate ideas. With consent, the discussion was recorded using a small digital recorder to 
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capture all thoughts for further consideration after the event. This culminated in a set of consensus priorities 
being documented. DC conducted further analysis of these priorities to collate and combine similar issues and 
summarise key patient priorities (further details below), validated by the audio recordings of the event and in 
the context of existing research or gaps in the field (identified by the systematic review), to form a summary 
of the key issues. The summary formed the basis for the consultation document shared with patients and 
carers online in the second part of the patient consultation process.  
Social media and email consultation of patients and carers 
The summary patient priorities document, presenting the identified priorities with free text comment boxes, 
(modelled on the second round of an online eDelphi questionnaire approach) was shared with a group of 
online service users and their family members using Twitter as a platform in addition to online Maggie’s 
Centre and, with permission, local patient support groups, to encourage further engagement and consultation 
on what is relevant as a priority in the current research and policy climate. A brief outline and link to the full 
document (via Survey Monkey) was posted on Twitter. To reach a wide audience, relevant organisations such 
as the National Institute for Health Research’s INVOLVE, Our Voice Scotland, and the Alliance were tagged in 
order to invite their feedback. It was anticipated that the Twitter post would be shared by tagged online 
groups to highlight awareness of the consultation. Interested parties could post a comment with their views, 
or use the online link or contact the research team to request a paper copy of the consultation document with 
FREEPOST return envelope. Attendees at the consultation workshop were also sent the consultation 
document and asked for comments and feedback on each priority.  
Academic expert consultation 
In order to further broaden the reach of the consultation, the document was also emailed separately to 
twenty professional stakeholders –academics (including clinical academics) who have published research on 
cancer survivorship and multimorbidity -for their input, reflective of the third round of an eDelphi online 
questionnaire (26). Feedback from this exercise confirmed and added to the themes identified in the first 
component. These were contrasted and compared with the identified gaps in the literature from the 
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systematic review (16). Close parallels were drawn between the findings from the evidence synthesis and 
patient priorities identified via the prioritisation exercise. These were combined to inform the development of 
an empirical study; in particular, the research questions and the interview schedule for in-depth patient and 
carer interviews to be carried out by the authors.  
The issues raised through the consultation were not subject to formal qualitative data analysis but did 
undergo an analytic process to group and summarise shared patient and academic expert priorities and link 
them with existing gaps in the literature identified in a separately published systematic review and evidence 
synthesis to produce priorities for research (16). Issues identified at the workshop were initially added to a 
list. After the event, DC reviewed the list and looked for commonalities or overlap and merged points where 
deemed appropriate. These merged points were given overarching labels, thus generating the topics 
identified as priority issues. Further input from the online consultation with patients and academic 
stakeholders were used to refine or expand the priorities established as a result of combining the workshop 
and patient consultation with outputs from the systematic review, loosely following an online eDelphi 
approach, without explicitly ranking priorities (26, 28). This added to topics being expanded or new topics 
generated e.g. support for carers.  
Patient and Public Involvement 
Dr Allison Worth (PPI advisor for the Wellcome Trust Clinical Research Facility) and G.W., a Wellcome Trust 
consumer panel member read and commented on the proposed consultation and supporting documents 
(advertising poster, attendee information sheet, agenda and proposed content of discussion).  The consumer 
member of the study advisory group, EB, supported the design and planning of the consultation event and its 
outcomes, including commenting on all documentation. An additional attendee at the consultation workshop 
was invited to join the research team as a consumer advisor for the remainder of the project.    
Outputs generated from the research prioritisation process 
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There were six attendees at the initial workshop to highlight topics for research, feeding into the consultation 
document, a much smaller number than anticipated. Due to the nature of their involvement, personal 
demographic information or details of their health were not recorded. However, all attendees self-reported at 
least one diagnosis of cancer (including bowel, breast and prostate) and one other long term condition 
(including heart disease, diabetes and chronic pain).  
The online consultation generated a total of ten responses, again a smaller number of responses than 
anticipated. Of a total of 20 international academic experts contacted, eight responded or asked a member of 
their research team to respond on their behalf, representing countries including the UK, USA, Holland, 
Denmark and Australia.  
Issues that can be attributed to the experience of cancer in general were given emphasis by those consulted, 
without reference to comorbid illnesses. Topics identified included: issues related to the burden of cancer-
related and treatment side effects; psychological distress, anxiety, uncertainty and fear of recurrence; lack of 
information provision and poor communication between patient and doctors and between hospital and 
primary care doctors; social isolation, support and the timing of appropriate support; seeking some 
semblance of normality, routine and functioning in everyday life; and practical concerns, finances and 
insurance. The online consultation identified supported self-management, including advice and support on 
lifestyle and nutrition after cancer as a patient and stakeholder priority.  Self-management for those with 
cancer and comorbid conditions was also identified as a research gap in the literature review. Research 
exploring the experience of cancer and comorbid illness will necessarily feature these topics and 
consideration is needed of how they extend to and influence living with additional chronic illness.  
The key issues arising that applied to the experience of cancer and additional long term illnesses are set out 
below and summarised in Box 1. They have been arranged according to broad themes although many of the 
issues are cross-cutting.  
 
The diagnostic journey 
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The diagnosis of cancer was viewed as being a crucial moment in the health care trajectory and cancer 
journey, associated for the most part with fear, shock and distress; although in some cases possibly with relief 
also. Those consulted talk about their lives being turned upside down in an instant. Potential questions 
identified for research included a comparison of the experience of diagnosis of cancer versus another 
condition, with issues such as cancer and other disease type, severity and the sequencing of the illnesses 
being pertinent. Further consultation and analysis of feedback highlights the meaning ascribed to cancer in 
comparison to other conditions as being a relevant line of enquiry, with implications for illness identity.  
 
The burden of symptoms 
Those consulted discussed the importance of looking at the impact on people’s bodies and emotions of having 
to deal with complex and varied symptoms of more than one condition as well as treatment side effects. It 
was viewed as key to explore the impact on managing daily living.  
 
Another issue identified was the ability to make a distinction between the symptoms from the cancer or side 
effects of cancer treatment versus the symptoms from the other illness. A qualitative inquiry could explore 
any potential difference in the types of symptoms experienced and varying severity. Related to this are the 
varying kinds of symptoms people may experience depending on the type of cancer and the nature of their 
other illness. For example, for some the cancer may be treated but they are left with enduring (and/or 
exacerbated) symptoms from their other condition(s) or vice versa, which changes the experience of moving 
on from cancer. Research in this area would need to consider this carefully at the design stage. Finally, the 
potential blurring of symptoms - when it was not possible to know which illness was causing them; especially 
for general symptoms such as tiredness or dizziness – and discerning who, where and when to seek help was 
highlighted as a priority.  
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Managing medications  
 A number of areas related to medications were highlighted as of potential interest for research, including 
managing multiple drug regimes. Management issues such as drug interactions, contraindications and their 
potential for unwanted side effects and emergencies (related to communication between health professionals 
about medications) were also raised. The impact of existing medication on side effects, treatment and trial 
participation were also identified in the second stage of the consultation to warrant research attention.  
 
Addressing the needs of informal carers 
Exploration of the impact on carers was also identified as a priority in the online and academic expert 
consultations. This was identified as a broad and general topic to be qualitatively explored to identify carers’ 
unique support needs related to helping patients manage the multi-dimensional aspects of complex illness.  
 
Service provision 
The final area highlighted as being a relevant area for research exploring the experience of cancer and 
comorbid illness is that of service provision. Issues of receiving good quality of care were raised and 
exploration of the potential tensions between the need for holistic thinking when addressing individual needs 
versus fragmented care were identified as a gap in the evidence base. Those consulted suggested that 
individuals are being followed up separately by more than one specialist and their primary care providers, and 
described being ‘passed from pillar to post’ with a lack of joined up care. Further qualitative investigation of 
this issue is required to understand more fully the experience of service provision for those with multiple 
conditions. Other related points identified included communication between primary and secondary care or 
between secondary care providers (potentially influenced by complex health conditions and an increased 
number of people involved in a patient’s care); the role of specialist support and reassurance (having a 
‘hotline to the specialist’ versus GP care); management of follow-up for multi-morbid cancer patients; and the 
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impact of comorbid conditions on cancer treatment decision making (as discussed in relation to managing 
medications). Self-management and supported self-management were also highlighted as key areas for 
research on patient, carer and professional views to help manage the challenges of survivorship care for 
people with complex health needs.  
 
Box 1: Issues identified for further qualitative inquiry   
 
Discussion 
Summary 
Living with and beyond cancer has become a key topic of interest in cancer experience research. The added 
complexity of comorbid conditions among cancer survivors is one important dimension prioritised by a recent 
NCRI and James Lind Alliance initiative (https://www.ncri.org.uk/lwbc/#lwbc_questions). This report of a 
research prioritisation exercise focuses on issues relating to living with and beyond cancer with comorbid 
illness, tying in with priority three of the NCRI ‘top ten’.  
 Explore the complex symptom experience, blurring of symptoms, and the intersection with perceptions 
and expectations of ageing. 
 Help-seeking and negotiating health services for more than one illness. 
 Exploring illness identity and the meaning of cancer in comparison to the other illness, with attention to 
issues such as cancer and other illness type, severity and sequencing.  
 Ascertain views on the notion of holistic care and continuity of care between specialists and other health 
and social care providers and the challenges of providing this form of care.  
 Explore preferences for treatment decision-making, professional support and follow-up, including views on 
specialist versus primary care.  
 Examine views on self-management and supported self-management 
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A one-off workshop and an online consultation have combined with a systematic literature review to identify 
pervasive issues related to living with and beyond cancer as well as those associated with complex 
combinations of disease. The diagnostic journey (comparing pathways; issues of severity and sequencing of 
conditions), The burden of symptoms (complexity, comparison and blurring of symptoms), managing 
medications (polypharmacy and drug interactions), addressing carer needs (helping to manage complex 
illness) and issues of service provision (negotiating health services, holistic care, professional support and 
follow-up and supported self-management)have all been identified as areas where more exploratory research 
is needed to understand people’s views and experiences in these circumstances.  
This exercise, combined with a systematic review of the literature that has identified gaps in the qualitative 
evidence base that map onto patient-identified priorities (16), has highlighted key issues (as listed above) that 
appear to be central to the experience of cancer with additional conditions. This approach, working in 
partnership with people living with and beyond cancer, has identified priorities for future empirical research.   
Reflections on the research prioritisation process 
A patient partnership and stakeholder involvement approach was adopted to plan meaningful and relevant 
research to ultimately influence policy and practice and improve care for patients and their families. However, 
it is important to consider one’s own assumptions in influencing interpretations of priorities in order to fit in 
with planned research. Practicing reflexivity is key and keeping an open agenda for topics to be added to can 
help to address these concerns (36).  
Going into this exercise, the research team held certain assumptions that is it important to surface here and 
consider the extent to which they were challenged. The team are interested in psychosocial aspects of living 
with and beyond cancer and so cancer was the index condition in relation to other comorbid illness. Therefore 
cancer has already been implicitly prioritised as the centre of patients’ stories. Hearing suggestions of illness 
identity and prioritisation of conditions as being more complex, and cancer not always being at the centre of 
people’s lives (depending on the type and severity of the cancer and comorbidities), has challenged this 
assumption.  
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There can also be a mismatch between patients’, clinicians’ and the research community’s priorities for 
research, so taking a partnership approach involving the views of all of these groups was important to inform 
the priorities set and shape future work (37). There is an additional danger of a ‘policy disconnect’ [as 
described by Alan Irwin in his critical review of public involvement in relation to science and technology 
research (38)], where there is a lack of evidence that patient partnership work is taken forward and leads to 
tangible changes in care provision. It can often be difficult to see the thread from prioritisation and then 
research through to improved care and experience, particularly in studies exploring more conceptual 
dimensions of living with illness. The steps in providing the evidence base are often slow from early 
consultation and exploratory work, to more focused topic work before reaching practical interventions that 
may be shown to improve patient care. Embedding these in sustained provision of care in a resource 
constrained National Health Service is yet another challenge.  
Limitations of the exercise 
Ultimately, this consultation did not generate as much involvement and feedback as was anticipated and 
planned for by the research team, impacting on confidence in the consensus reached, as set out in the Delphi 
approach (28). Although limited by time and financial resources, there are important lessons to be learned 
about mitigation planning and a flexible approach to enable expansion on consultation methods in response 
to low interest. People’s motivations for patient involvement are complex (39). Upon reflection, it is possible 
that ill health and limited mobility prevented people from becoming involved, which will have included travel 
for some. There are also possible social or structural barriers: perhaps people did not feel they qualified to 
represent others in this way or comfortable working in an academic environment on such a project? It 
certainly felt as though there was more groundwork to be done in terms of building productive relationships 
and allowing people time to share their personal stories before moving forward to a shared research agenda, 
suggesting that a longer term process may have generated different, and possibly better, outcomes. To this 
end, a second workshop after the online consultation would have helped to consolidate or expand on the 
priorities identified in the initial workshop and reach a clearer consensus but resource and time constraints 
did not permit this.  
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There are also limitations to the number of people taking part in the consultation and reflections to be made 
on the planning process to ensure a broader scope and diversity of consultants, speaking to existing debates 
around whether or not patient involvement includes the voices of a wide enough group of people, including 
those from marginalised groups and those less able to expertly self-advocate and articulate their views and 
beliefs (32). This brings into question whether formal training should be offered to more people in order to 
empower and enable people of all backgrounds to engage with the involvement process more fully (40). This 
sits within a wider critical debate about the role of and spaces occupied by participatory research (33, 40) and 
potential power imbalances in the context of citizen science and consumer accountability (41-43). The 
importance of bringing in evidence relating to gaps in the literature identified in the aforementioned 
systematic review carried out by the authors as well as subsequent empirical research to capture the diverse 
needs of patients living with and beyond cancer with comorbid conditions, is also heightened, to contribute to 
a robust evidence base with transferable findings.  
DC is also a relative novice in doing this form of patient involvement work and so there were lessons to be 
learned in terms of publicising the event and online consultation, as well as a lack of power and influence in 
reaching certain groups and being heard. Approaches where invitations came from a trusted source, e.g. 
posters in clinic rooms or personal invitations endorsed by online patient group coordinators, appeared to be 
more successful than social media appeals with endorsement of trusted sources.  Employing a wider range of 
strategies for finding people in order to invite them to be involved in this consultation, such as via community 
groups and councils, may have been a better approach (44). 
This research prioritisation exercise did pose some challenging questions around the blurring of the 
boundaries between patient involvement work and research. It problematises what counts as research data 
and therefore how the study should be designed and the ethical considerations managed, including the role 
of formal ethical review (procedural ethics).  These issues seem particularly pertinent in relation to scenarios 
such as this exercise where information is being generated that will be used to support research and policy 
impact.  The line between treating the discussion as informing research and as research data can be blurred:  
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this paper is an example of that ambiguity. However, important steps have been taken to clarify this 
distinction, both here and in the broader literature, and a call for transparency and clarity in reporting of 
engagement work (45).  The engagement process employed a sensitive and considered ethical approach and 
went through required institutional approval (Usher Research Ethics Group).  It was clear that people were 
being asked to join the researchers as partners in a process of collaborative information collection, and the 
discussions were summarised and key issues identified, rather than analysed as they would be in a qualitative 
research process. However, a social constructionist approach to intersubjective data generation is arguably 
not that different; neither is a thematic analysis. While we feel confident in our own ethical position, we are 
nonetheless uncomfortable operating within the ambiguous space of patient involvement in research that is, 
if it is to be effective, generative of relevant information in a research context.  We would argue that a new 
approach to ethics is needed in this environment to work with this tension and to reassure both researchers 
and patient participants that an appropriate form of ethical review has been undertaken and that ethical 
issues will continue to be reflected upon during the process of the engagement and subsequent research.  
This is all the more important as PPI is increasingly a core component of research in the UK (46).  
This consultation did not undergo formal evaluation but it was clear that those involved helped to validate the 
thinking of the research team and contributed topics that would not otherwise have been identified without 
consulting stakeholders.  We would argue that more attention needs to be paid to evaluation, including by 
self-reflection, and for this to contribute to the evidence base for PPI.   
Conclusion 
Including patients in the consultation in addition to academics and clinicians with a broad view of the research 
landscape on an international stage aims to lead to more meaningful and relevant in-depth research and, 
ultimately, to corresponding interventions that will improve patient, carer and provider experience.  
Findings from this research prioritisation exercise will directly inform further in-depth research exploring 
experience of cancer and other comorbid conditions as topics identified will be integrated into a planned 
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interview study with patients and carers. On a broader scale, reflections on the consultation will contribute to 
understandings of the role of patient partners in the research process. It can provide the foundations for 
future work to provide outputs that are relevant and meaningful, not only to patients, but to policy makers, in 
order to make recommendations for health and social care services in Scotland, as elsewhere, and improve 
patient experience, to meet the targets set out by Better Cancer Care (11).   
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